Edgemont in the News

David Blume, Managing Director, Quoted on Outsourcing-Pharma

Read more here: http://www.outsourcing-pharma.com/Clinical-Development/Expert-predicts-more-CROs-will-buy-trial-sites-after-Icon-deal